News on E%26J %27s Bio-concepts from BioPortfolio.com http://www.BioPortfolio.com Consolidated E%26J %27s Bio-concepts news from BioPortfolio.com Tue, 09 Feb 2010 22:23:46 GMT en Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037712&HITNO=0&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037712&THISHREF=http://c.moreover.com/click/here.pl%3fz2537245827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037712&HITNO=0&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037712&THISHREF=http://c.moreover.com/click/here.pl%3fz2537245827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Cara Therapeutics Reports Positive Phase II Data For Novel Peripheral Analgesic In Acute Post-Operative Painhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036069&HITNO=1&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036069&THISHREF=http://c.moreover.com/click/here.pl%3fz2536485927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036069&HITNO=1&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036069&THISHREF=http://c.moreover.com/click/here.pl%3fz2536485927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Positive data from Cara Therapeutics' peripherally-restricted kappa opioid agonist Phase II trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033381&HITNO=2&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033381&THISHREF=http://c.moreover.com/click/here.pl%3fz2535172250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033381&HITNO=2&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033381&THISHREF=http://c.moreover.com/click/here.pl%3fz2535172250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037856&HITNO=3&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037856&THISHREF=http://c.moreover.com/click/here.pl%3fz2537334210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037856&HITNO=3&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037856&THISHREF=http://c.moreover.com/click/here.pl%3fz2537334210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035957&HITNO=4&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035957&THISHREF=http://c.moreover.com/click/here.pl%3fz2536432438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035957&HITNO=4&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035957&THISHREF=http://c.moreover.com/click/here.pl%3fz2536432438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: PolyMedix Announces Planned Milestones for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035234&HITNO=5&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035234&THISHREF=http://c.moreover.com/click/here.pl%3fz2536162758%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035234&HITNO=5&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035234&THISHREF=http://c.moreover.com/click/here.pl%3fz2536162758%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Granta Design Launches New Version of CES EduPackhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032881&HITNO=6&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032881&THISHREF=http://c.moreover.com/click/here.pl%3fz2534846673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032881&HITNO=6&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032881&THISHREF=http://c.moreover.com/click/here.pl%3fz2534846673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: BIO-RAD Offers Liquichek Hematology and Reticulocyte Controls for Siemens ADVIA Instrumentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037108&HITNO=7&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037108&THISHREF=http://c.moreover.com/click/here.pl%3fz2536906583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037108&HITNO=7&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037108&THISHREF=http://c.moreover.com/click/here.pl%3fz2536906583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAdvance for Administrators of the Laboratory: Cara Therapeutics Reports Positive Phase II Data for Novel Peripheral Analgesic in Acute Post-Operative Painhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029598&HITNO=8&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029598&THISHREF=http://c.moreover.com/click/here.pl%3fz2533202853%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029598&HITNO=8&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029598&THISHREF=http://c.moreover.com/click/here.pl%3fz2533202853%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Cara Therapeutics Reports Positive Phase II Data for Novel Peripheral Analgesic in Acute Post-Operative Painhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031577&HITNO=9&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031577&THISHREF=http://c.moreover.com/click/here.pl%3fz2534269263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031577&HITNO=9&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031577&THISHREF=http://c.moreover.com/click/here.pl%3fz2534269263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Emerging Drug Developer: Nile Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030231&HITNO=10&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030231&THISHREF=http://c.moreover.com/click/here.pl%3fz2533511688%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030231&HITNO=10&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030231&THISHREF=http://c.moreover.com/click/here.pl%3fz2533511688%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: 2/7/10 - FDA clears TransOral robotic surgery developed at Pennhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026575&HITNO=11&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026575&THISHREF=http://c.moreover.com/click/here.pl%3fz2530978903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026575&HITNO=11&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026575&THISHREF=http://c.moreover.com/click/here.pl%3fz2530978903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: NeurogesX to Present at BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026260&HITNO=12&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026260&THISHREF=http://c.moreover.com/click/here.pl%3fz2530548589%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026260&HITNO=12&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026260&THISHREF=http://c.moreover.com/click/here.pl%3fz2530548589%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Gene Doping and Sports: The Genetic Enhancement Frontier?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024334&HITNO=13&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024334&THISHREF=http://c.moreover.com/click/here.pl%3fz2528822506%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024334&HITNO=13&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024334&THISHREF=http://c.moreover.com/click/here.pl%3fz2528822506%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedia Newswire: In Brief This Week: Bio-Rad Laboratories; TGen, Van Andel Research Institute; Infosys, Elan; Dotmatix, Boehrinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024013&HITNO=14&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024013&THISHREF=http://c.moreover.com/click/here.pl%3fz2528570227%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024013&HITNO=14&MSIZE=133&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=E%26J%20's%20Bio-concepts&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024013&THISHREF=http://c.moreover.com/click/here.pl%3fz2528570227%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: